Skip to main content
Clinical Trials/NCT03230877
NCT03230877CompletedNot Applicable

The Evaluation of a Full Face Mask Seal for the Treatment of Obstructive Sleep Apnea

Fisher and Paykel Healthcare2 sites in 1 country38 target enrollmentStarted: September 2, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
38
Locations
2
Primary Endpoint
Trial Mask Seal Acceptability

Study Overview

Brief Summary

The investigation is a prospective, randomized, single blinded, crossover study. The investigation is designed to evaluate the performance, comfort and ease of use of the F&P Trial Full Face Mask Seal amongst Obstructive Sleep Apnea (OSA) participants. A total number of 40-45 OSA participants will be recruited for the trial by the investigation site

Detailed Description

This study will involve three visits to the investigation site. During visit one participants will be randomized to, fitted with and issued with the first trial mask seal for use in- home for 7 ±4 days.

The participants will then come in to return the mask seal and be fitted and issued with the second trial seal for use in home for 7±4 days.

Visit Three will involve the participants returning the second trial seal and providing feedback.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
22 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult (22+ years of age)
  • Able to give informed consent
  • Apnea hypopnea Index (AHI) ≥ 5 on diagnostic night
  • Either prescribed Automatic positive airway pressure (APAP), Continuous positive airway pressure (CPAP) or Bi-level positive airway pressure (PAP) for OSA
  • Fluent in spoken and written English
  • Existing F&P full face mask user

Exclusion Criteria

  • Inability to give informed consent
  • Participant intolerant to PAP
  • Anatomical or physiological conditions making PAP therapy inappropriate
  • Current diagnosis of respiratory disease or carbon Dioxide (CO2) retention
  • Pregnant or may think they are pregnant.

Outcomes

Primary Outcomes

Trial Mask Seal Acceptability

Time Frame: 14 ± 4 days in-home

Preference for trial mask determined from questionnaires at the end of the trial - Subjective

Trial Mask Seal Comfort

Time Frame: 7 ± 4 days in-home

Overall seal comfort determined from questionnaires- Subjective

Secondary Outcomes

  • Trial Mask Seal Usability(1 hour day-time appointment)
  • Trial Mask Seal Treatment Performance - Objective(7 ± 4 days in-home)
  • Trial Mask Seal Treatment Performance- Subjective(7 ± 4 days in-home)

Investigators

Sponsor
Fisher and Paykel Healthcare
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials